SAN DIEGO, Jan. 21, 2016 -- Medical Marijuana, Inc. (OTC Pink:MJNA) is proud to announce its support of a cannabidiol (CBD) hemp oil educational event Sunday, January 24, 2016 in Mexico City, hosted by our premier charitable partner, the “Por Grace Foundation.”
The cannabis movement is quickly progressing in Mexico starting with Congressional hearings set to begin on Monday, January 25th. Medical Marijuana, Inc., Dr. Bronner’s Mexico, Heaven Grown, Be Hemp and Cañamo Magazine, along with the Por Grace Foundation will be sponsoring a historic event in Mexico City called, “Cannabis: Medical and Industrial Uses In Mexico” taking place January 24 at the Sheraton.
The “Por Grace Foundation” was created by Raul Elizalde, the outspoken father of 8-year-old Grace. She was diagnosed with a rare and severe form of childhood epilepsy called Lennox-Gastaut syndrome (LGS) which triggers up to 400 seizures a day. Grace’s family was the first to be granted special permission last year to legally import cannabidiol (CBD) into Mexico.
The goal of the “Por Grace Foundation” is to make sure Mexican families receive the right to health care, and inform parents with sick children whose quality of life can be dramatically improved with CBD hemp oil. More than 100 families will be attending the Mexico City event. One of those families struggling to care for a sick child is Abelardo Maldonado. He is the father of 11-year-old Alina Maldonado Montes de Oca-- who is battling drug-resistant epilepsy and infantile cerebral palsy. Medical Marijuana, Inc. has teamed up with the “Aguinaco Abogados” law firm in Mexico to help Alina’s family fight for legal access to CBD hemp oil. After nearly four months of fighting in the courts, Alina’s family will hopefully soon become the second family to receive permission from the Mexican government to import CBD hemp oil into Mexico. Alina’s parents have created a Change.org petition which has received more than 128,000 signatures, supporting the family’s endeavor to get permission from the government to import CBD hemp oil.
“This is a historic time in Mexico, and none of this could have been accomplished without the help of a coalition of hundreds of families in Mexico. Together, they are helping bring down the walls, which will forever change the face of legalization in Mexico, and in turn will help re-shape the economies of both Mexico and the U.S.,” states Stuart W. Titus, PhD and Chief Executive Officer of Medical Marijuana, Inc.
Titus and several other leaders in this movement are set to speak at the Mexico City event, including a highly respected neurologist, Dr. Saul Garza Morales. Click here to view the full program for the event.
Then on January 26th, Medical Marijuana, Inc. will also be sponsoring an all-day expo at Restaurante Labna in Cancun, the same day the national public debates on marijuana kick-off. After the debate join: Medical Marijuana, Inc., Dr. Bronner’s Mexico, Heaven Grown, Be Hemp and Cañamo Magazine at Restaurante Labna to learn more and discuss what unfolded during day one of the public debates.
On site contact in Mexico: Tiffany Jackson. [email protected] or (516) 242-8142, text or email preferred.
About Medical Marijuana Inc.
The mission of Medical Marijuana, Inc. (OTC Pink:MJNA) is to be the premier hemp industry innovator, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company's website at: www.MedicalMarijuanaInc.com.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
LEGAL DISCLOSURE
Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
For further information, please contact: Public Relations contact: Andrew Hard Chief Executive Officer CMW Media P. 888-829-0070 [email protected] www.cmwmedia.com Corporate contact: Medical Marijuana, Inc. Toll Free: 888-OTC-MJNA (888-682-6562) www.medicalmarijuanainc.com www.facebook.com/mjnainc


iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids
Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation
Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs 



